- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04840043
Osteopathic Sympathetic Harmonization and Depression
April 7, 2021 updated by: Ömer Osman PALA, Cumhuriyet University
Assessment of Effectiveness of the Osteopathic Sympathetic Harmonization Applications on the Sympathetic Nervous System and the HPA Axis With Depression Diagnosed Adolescents: A Double-blind, Placebo-controlled, Randomized Study
Depression appears to be resistant to the available pharmacological treatments.
Autonomic responses accompanied by any psychological stress are sympathetic nervous system (SNS) and neuroendocrine responses are formed by hypothalamus-pituitary-adrenal (HPA) axis.
The purpose of this study is; assessment of effectiveness of osteopathic approach on sympathetic nervous system and HPA axis in adolescents with depression.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Depression diagnosed and volunteer to participate 39 cases who between the ages of 15-21 included.
All participants were recruited and randomly assigned into two groups, the osteopathy group (OG) and the placebo group (PG).
Stimulation on the sympathetic truncus and prevertebral ganglia were performed in the OG group.
The stimulation of the PG group was performed with a lighter touch and a shorter duration in similar areas.
Each participant was filled in the demographic data form, Beck Depression Scale and State and Trait Anxiety Inventory (STAI Form - 1 and Form - 2) before the application.
Emotional state visual analog scale and STAI Form - 1 was filled and blood pressure and pulse measurement were made and saliva sample was taken before application, immediately after application and 20 minutes after application.
Study Type
Interventional
Enrollment (Actual)
39
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Si̇vas, Turkey, 58140
- Sivas Cumhuriyet University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 21 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- To be diagnosed with clinical depression by a psychiatrist according to The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria
- Volunteering to participate in the study
Exclusion Criteria:
- Fever over 38.5
- Acute injury or infection
- Rib fracture
- Cardiac arrhythmia
- Using drugs that affect cortisol levels (oral contraceptives, hormonal drugs, antidepressants, antipsychotics etc.)
- Being pregnant, premenstrual or in the menstrual period for female participants
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Osteopathy Group
Stimulation on the sympathetic truncus and prevertebral ganglia
|
Treatments that harmonize at the sympathetic nerves or plexus, e.g., sympathetic trunk stimulation by means of the rib-raise technique or stimulation of the prevertebral ganglia.
|
Sham Comparator: Control Group
Stimulation on similar areas with lighter touch and shorter duration
|
Different location, size and time of the rib-raise technique or stimulation of the prevertebral ganglia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Beck Depression Inventory (BDI)
Time Frame: Before intervention
|
The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression.
|
Before intervention
|
The State-Trait Anxiety Inventory (STAI) Form - 1
Time Frame: Before intervention
|
The State-Trait Anxiety Inventory (STAI) is a commonly used measure of trait and state anxiety.
It can be used in clinical settings to diagnose anxiety and to distinguish it from depressive syndromes.
It also is often used in research as an indicator of caregiver distress.
|
Before intervention
|
Change from Baseline The State-Trait Anxiety Inventory (STAI) Form - 2 at 20 minutes
Time Frame: Before intervention, immediately after the intervention, 20 minutes after the intervention
|
The State-Trait Anxiety Inventory (STAI) is a commonly used measure of trait and state anxiety.
It can be used in clinical settings to diagnose anxiety and to distinguish it from depressive syndromes.
It also is often used in research as an indicator of caregiver distress.
|
Before intervention, immediately after the intervention, 20 minutes after the intervention
|
Change from Baseline Heart rate and blood pressure measurements at 20 minutes
Time Frame: Before intervention, immediately after the intervention, 20 minutes after the intervention
|
Heart rate (beats per minute) and blood pressure (mm/Hg) were measured with automatic blood pressure monitor (the Microlife BP 3BT0-A).
It is a clinically validated and 1-star automatic blood pressure monitor
|
Before intervention, immediately after the intervention, 20 minutes after the intervention
|
Change from Baseline Salivary Biomarkers at 20 minutes
Time Frame: Before intervention, immediately after the intervention, 20 second after the intervention
|
Salivary a-amylase and cortisol levels were measured for each sample.
These biomarkers were analysed Enzyme-Linked Immunosorbent Assay.
|
Before intervention, immediately after the intervention, 20 second after the intervention
|
Demographic data
Time Frame: Before intervention
|
Sex; male or female
|
Before intervention
|
Demographic data
Time Frame: Before intervention
|
Age; years
|
Before intervention
|
Demographic data
Time Frame: Before intervention
|
Height (m); weight (kg); body mass index (kg/m2)
|
Before intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Omer Osman PALA, PhD, Cumhuriyet University, Faculty of Health Sciences, Physiotherapy and Rehabilitation
- Principal Investigator: Seyit CITAKER, Prof, Gazi University, Faculty of Health Sciences, Physiotherapy and Rehabilitation
- Principal Investigator: Esra GUNEY, Assoc. Prof, Gazi University, Faculty of Medicine, Child and Adolescent Psychiatry
- Principal Investigator: Aylin SEPICI DINCEL, Prof, Gazi University, Faculty of Medicine, Medical Biochemistry
- Principal Investigator: Güner Melike GUVELI, MD, Gazi University, Faculty of Medicine, Child and Adolescent Psychiatry
- Principal Investigator: Burak ARSLAN, MD, Gazi University, Faculty of Medicine, Medical Biochemistry
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 11, 2017
Primary Completion (Actual)
March 23, 2018
Study Completion (Actual)
June 5, 2018
Study Registration Dates
First Submitted
April 4, 2021
First Submitted That Met QC Criteria
April 7, 2021
First Posted (Actual)
April 9, 2021
Study Record Updates
Last Update Posted (Actual)
April 9, 2021
Last Update Submitted That Met QC Criteria
April 7, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-16-1106
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Sharing Time Frame
January 1, 2022
IPD Sharing Supporting Information Type
- Clinical Study Report (CSR)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteopathic Manipulative Treatment
-
I.R.C.C.S. Fondazione Santa LuciaCompletedOsteopathic Manipulative TreatmentItaly
-
A.T. Still University of Health SciencesAmerican Academy of Osteopathy; A.T. Still Research Institute; DO-Touch.NETCompletedOsteopathic Manipulative Treatment
-
Midwestern UniversityCompletedUltrasonography | Osteopathic Manipulative TreatmentUnited States
-
Federal University of São PauloCompletedIntraocular Pressure | Osteopathic Manipulative TreatmentBrazil
-
Universidade Norte do ParanáCompletedLow Back Pain | Osteopathic Manipulative TreatmentBrazil
-
Midwestern UniversityCompletedKnee Arthroplasty | Gait, Unsteady | Osteopathic Manipulative Treatment | Knee ArthroscopyUnited States
-
University of Wisconsin, MadisonRecruitingOsteopathic Manipulative Treatment | Hemiplegic Shoulder PainUnited States
-
AdventHealthTerminatedOsteopathic ManipulationUnited States
-
University of MinnesotaCompletedManipulation, OsteopathicUnited States
-
A.T. Still University of Health SciencesCompleted
Clinical Trials on Osteopathic sympathic harmonization
-
Universidade do PortoCompletedTrapezius Muscle StrainPortugal
-
Assistance Publique - Hôpitaux de ParisCompleted
-
New York Institute of TechnologyRecruitingParkinson's Disease | ConstipationUnited States
-
Ohio UniversityAmerican Osteopathic FoundationCompletedSARS-CoV2 Infection | COVID-19 Lower Respiratory InfectionUnited States
-
Come CollaborationUniversity of ChietiCompleted
-
Nova Scotia Health AuthorityCompleted
-
New York Institute of TechnologyActive, not recruitingDistorted; Balance | Post-Concussion SymptomsUnited States
-
Universitat de LleidaRecruitingFibromyalgia | Temporomandibular DisorderSpain
-
College Osteopathique de Provence Aix-MarseilleUniversity Hospital, MarseilleRecruitingSickle Cell DiseaseFrance
-
Ecole d'ostéopathie de ParisUniversity of Paris 5 - Rene DescartesCompleted